Nothing changes the fact that Imagine failed two years ago. The company fails to do any new trials. FDA is correct to hold it since it is a basic principle to pass animal test before human trials. The company fails to do human trials in other territories as what they suggested one year ago. Therefore the share price is still below ten cents. The market has no interest in Prana related news from AAIC 2016, that is the fact concluded from this conference.
AAIC 2016 talks, page-61
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $1.247K | 384.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 52935756 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 127950526 | 19 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |